1. Fritz JD, Jayanthi LD, Thoreson MA, Blakely RD. Cloning and chromosomal mapping of the murine norepinephrine transporter. J Neurochem 1998;70:2241–2251. PMID:
9603188.
2. Hahn MK, Blakely RD. Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders. Pharmacogenomics J 2002;2:217–235. PMID:
12196911.
3. Huang SY, Lu RB, Ma KH, Shy MJ, Lin WW. Norepinephrine transporter polymorphisms T-182C and G1287A are not associated with alcohol dependence and its clinical subgroups. Drug Alcohol Depend 2008;92:20–26. PMID:
17630229.
4. Uhl GR, Johnson PS. Neurotransmitter transporters: three important gene families for neuronal function. J Exp Biol 1994;196:229–236. PMID:
7823024.
5. Torres GE, Gainetdinov RR, Caron MG. Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci 2003;4:13–25. PMID:
12511858.
6. Haenisch B, Bilkei-Gorzo A, Caron MG, Bonisch H. Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression. J Neurochem 2009;111:403–416. PMID:
19694905.
7. Takahashi H, Fujie S, Camerer C, Arakawa R, Takano H, Kodaka F, et al. Norepinephrine in the brain is associated with aversion to financial loss. Mol Psychiatry 2013;18:3–4. PMID:
22349782.
8. Bruss M, Kunz J, Lingen B, Bonisch H. Chromosomal mapping of the human gene for the tricyclic antidepressant-sensitive noradrenaline trans-porter. Hum Genet 1993;91:278–280. PMID:
8478011.
9. Porzgen P, Bonisch H, Bruss M. Molecular cloning and organization of the coding region of the human norepinephrine transporter gene. Biochem Biophys Res Commun 1995;215:1145–1150. PMID:
7488042.
10. Ebstein RP, Benjamin J, Belmaker RH. Personality and polymorphisms of genes involved in aminergic neurotransmission. Eur J Pharmacol 2000;410:205–214. PMID:
11134670.
11. Hahn MK, Blackford JU, Haman K, Mazei-Robison M, English BA, Prasad HC, et al. Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression. Genes Brain Behav 2008;7:487–495. PMID:
18081710.
12. Inoue K, Itoh K, Yoshida K, Shimizu T, Suzuki T. Positive association between T-182C polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a japanese population. Neuropsychobiology 2004;50:301–304. PMID:
15539861.
13. Kim CH, Hahn MK, Joung Y, Anderson SL, Steele AH, Mazei-Robinson MS, et al. A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proc Natl Acad Sci USA 2006;103:19164–19169. PMID:
17146058.
14. Min W, Li T, Ma X, Li Z, Yu T, Gao D, et al. Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response. Psychopharmacology (Berl) 2009;205:409–417. PMID:
19468717.
15. Yoshida K, Takahashi H, Higuchi H, Kamata M, Ito K, Sato K, et al. Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms. Am J Psychiatry 2004;161:1575–1580. PMID:
15337646.
16. Stober G, Nothen MM, Porzgen P, Bruss M, Bonisch H, Knapp M, et al. Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders. Am J Med Genet 1996;67:523–532. PMID:
8950409.
17. Zill P, Engel R, Baghai TC, Juckel G, Frodl T, Muller-Siecheneder F, et al. Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression. Neuropsychopharmacology 2002;26:489–493. PMID:
11927173.
18. Kim CH, Kim HS, Cubells JF, Kim KS. A previously undescribed intron and extensive 5' upstream sequence, but not Phox2a-mediated transactivation, are necessary for high level cell type-specific expression of the human norepinephrine transporter gene. J Biol Chem 1999;274:6507–6518. PMID:
10037744.
19. Ham BJ, Choi MJ, Lee HJ, Kang RH, Lee MS. Reward dependence is related to norepinephrine transporter T-182C gene polymorphism in a Korean population. Psychiatr Genet 2005;15:145–147. PMID:
15900230.
20. Lee BC, Yang JW, Lee SH, Kim SH, Joe SH, Jung IK, et al. An interaction between the norepinephrine transporter and monoamine oxidase A polymorphisms, and novelty-seeking personality traits in Korean females. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:238–242. PMID:
17920180.
21. Samochowiec J, Rybakowski F, Czerski P, Zakrzewska M, Stepien G, Pelka-Wysiecka J, et al. Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationship to temperamental dimensions measured by the Temperament and Character Inventory in healthy volunteers. Neuropsychobiology 2001;43:248–253. PMID:
11340364.
22. Suzuki A, Matsumoto Y, Ishii G, Oshino S, Goto K, Otani K. No association between the -3081A/T polymorphism in the norepinephrine transporter gene promoter and personality traits in healthy subjects. Neurosci Lett 2007;425:192–194. PMID:
17845831.
23. Tsai SJ, Wang YC, Hong CJ. Norepinephrine transporter and alpha (2c) adrenoceptor allelic variants and personality factors. Am J Med Genet 2002;114:649–651. PMID:
12210281.
24. Yamano E, Isowa T, Nakano Y, Matsuda F, Hashimoto-Tamaoki T, Ohira H, et al. Association study between reward dependence temperament and a polymorphism in the phenylethanolamine N-methyltransferase gene in a Japanese female population. Compr Psychiatry 2008;49:503–507. PMID:
18702937.
25. Cloninger CR. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr Dev 1986;4:167–226. PMID:
3809156.
26. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry 1993;50:975–990. PMID:
8250684.
27. Cloninger CR. A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry 1987;44:573–588. PMID:
3579504.
28. De Fruyt F, Van De Wiele L, Van Heeringen C. Cloninger's psychobiological model of temperament and character and the Five-Factor Model of personality. Pers Individ Dif 2000;29:441–452.
29. Kunisato Y, Yamaguchi A, Suzuki S. Cloninger's temperament and character model and the big five. JPN J Pers 2008;16:324–334.
30. Shimonaka Y, Nakazato K, Gondo Y, Takayama M. NEO-PI-R and NEO-FFI Manual for the Japanese Version. Tokyo: Tokyo Shinri; 1999.
31. Samochowiec J, Syrek S, Michał P, Ryzewska-Wódecka A, Samochowiec A, Horodnicki J, et al. Polymorphisms in the serotonin transporter and monoamine oxidase A genes and their relationship to personality traits measured by the Temperament and Character Inventory and NEO Five-Factor Inventory in healthy volunteers. Neuropsychobiology 2004;50:174–181. PMID:
15292674.
32. Aoki J, Iwahashi K, Ishigooka J, Ikeda K. Association study on catechol-O-methyltransferase (COMT) Val158Met gene polymorphism and NEO-FFI. Psychiatry Res 2011;187:312–313. PMID:
21051090.
33. Yoshimura K, Nakamura K, Ono Y, Sakurai A, Saito N, Mitani M, et al. Reliability and validity of a Japanese version of the NEO Five Factor Inventory (NEO-FFI): a population-based survey in Aomori prefecture. JPN J Stress Sci 1998;13:39–47.
34. Inoue K, Itoh K, Yoshida K, Higuchi H, Kamata M, Takahashi H, et al. No association of the G1287A polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a Japanese population. Biol Pharm Bull 2007;30:1996–1998. PMID:
17917281.
35. Yamamoto BK, Novotney S. Regulation of extracellular dopamine by the norepinephrine transporter. J Neurochem 1998;71:274–280. PMID:
9648875.
36. Sesack SR, Hawrylak VA, Guido MA, Levey AI. Cellular and subcellular localization of the dopamine transporter in rat cortex. Adv Pharmacol 1998;42:171–174. PMID:
9327871.
37. Carboni E, Silvagni A, Vacca C, Di Chiara G. Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex. J Neurochem 2006;96:473–481. PMID:
16336224.
38. Bookman EB, Taylor RE, Adams-Campbell L, Kittles RA. DRD4 promoter SNPs and gender effects on Extraversion in African Americans. Mol Psychiatry 2002;7:786–789. PMID:
12192624.
39. Eichhammer P, Sand PG, Stoertebecker P, Langguth B, Zowe M, Hajak G. Variation at the DRD4 promoter modulates extraversion in Caucasians. Mol Psychiatry 2005;10:520–522. PMID:
15738935.
40. Golimbet VE, Alfimova MV, Gritsenko IK, Ebstein RP. Relationship between dopamine system genes and extraversion and novelty seeking. Neurosci Behav Physiol 2007;37:601–606. PMID:
17657431.
41. Smillie LD, Cooper AJ, Proitsi P, Powell JF, Pickering AD. Variation in DRD2 dopamine gene predicts Extraverted personality. Neurosci Lett 2010;468:234–237. PMID:
19897017.
42. Stein MB, Schork NJ, Gelernter J. A polymorphism of the β1-adrenergic receptor is associated with low extraversion. Biol Psychiatry 2004;56:217–224. PMID:
15312808.
43. Miller GE, Cohen S, Rabin BS, Skoner DP, Doyle WJ. Personality and tonic cardiovascular, neuroendocrine, and immune parameters. Brain Behav Immun 1999;13:109–123. PMID:
10373276.
44. Jonsson EG, Nothen MM, Gustavsson JP, Neidt H, Bunzel R, Propping P, et al. Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Psychiatry Res 1998;79:1–9. PMID:
9676821.
45. Garvey MJ, Noyes R Jr, Cook B, Blum N. Preliminary confirmation of the proposed link between reward-dependence traits and norepinephrine. Psychiatry Res 1996;65:61–64. PMID:
8953662.